JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB308433

Anti-HIF-1 alpha antibody [EPR16897-145]

  • 20ul selling size
  • RabMAb
  • Advanced Validation
  • Recombinant
  • KO Validated
  • What is this?

Be the first to review this product! Submit a review

|

(16 Publications)

Anti-HIF-1 alpha antibody [EPR16897-145] (ab308433) is a rabbit monoclonal antibody detecting HIF-1 alpha in Western Blot, Flow Cytometry (Intra), Flow Cytometry, IP, ICC/IF, ChIP. Suitable for Human, Mouse.

- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency

View Alternative Names

BHLHE78, MOP1, PASD8, HIF1A, Hypoxia-inducible factor 1-alpha, HIF-1-alpha, HIF1-alpha, ARNT-interacting protein, Basic-helix-loop-helix-PAS protein MOP1, Class E basic helix-loop-helix protein 78, Member of PAS protein 1, PAS domain-containing protein 8, bHLHe78

16 Images
Immunocytochemistry/ Immunofluorescence - Anti-HIF-1 alpha antibody [EPR16897-145] (AB308433)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-HIF-1 alpha antibody [EPR16897-145] (AB308433)

Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized HeLa (human cervical adenocarcinoma epithelial cell) cells labelling HIF-1 alpha with ab308433 at 1/100 (5.125 ug/ml) dilution, followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed antibody at 1/1000 2 ug/ml dilution (Green). Confocal images showing nuclear staining in HeLa cells treated with DFO (0.5 mM) for 24 hours and showing no staining in untreated HeLa cells.Image was taken with a confocal microscope(Leica-Microsystems, TCS SP8). ab195889 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at 1/200 2.5ug/ml dilution (Red). The Nuclear counterstain was DAPI (Blue). Secondary antibody only control : Secondary antibody is ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 2 ug/ml dilution.

Immunocytochemistry/ Immunofluorescence - Anti-HIF-1 alpha antibody [EPR16897-145] (AB308433)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-HIF-1 alpha antibody [EPR16897-145] (AB308433)

Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized HIF1A KO HCT 116 (HIF1A knockout human colorectal carcinoma epithelial cell), ab255394 cells labelling HIF-1 alpha with ab308433 at 1/100 (10.25 ug/ml) dilution, followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed antibody at 1/1000 2 ug/ml dilution (Green). Confocal images showing nuclear staining in wildtype HCT 116 cells treated with DFO (0.5mM) for 24 hours and showing no staining in HIF1A knockout HCT 116 cells treated with the same condition.Image was taken with a confocal microscope(Leica-Microsystems, TCS SP8). ab195889 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at 1/200 2.5ug/ml dilution (Red). The Nuclear counterstain was DAPI (Blue). Secondary antibody only control : Secondary antibody is ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 2 ug/ml dilution.

Flow Cytometry (Intracellular) - Anti-HIF-1 alpha antibody [EPR16897-145] (AB308433)
  • Flow Cyt (Intra)

Supplier Data

Flow Cytometry (Intracellular) - Anti-HIF-1 alpha antibody [EPR16897-145] (AB308433)

Flow cytometric analysis of 4% paraformaldehyde fixed 90% methanol permeabilized HeLa (human cervical adenocarcinoma epithelial cell) treated with 0.5mM DFO for 24h (Red) / untreated HeLa (Green) cells labelling HIF-1 alpha with ab308433 at 1/50 dilution (1 ug)/Red and Green (Red) compared with a Rabbit monoclonal IgG (ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). A Goat Anti-Rabbit IgG (Alexa Fluor® 488, ab150081) at 1/5000 dilution was used as the secondary antibody.

ChIP-sequencing - Anti-HIF-1 alpha antibody [EPR16897-145] (AB308433)
  • ChIP-seq

Supplier Data

ChIP-sequencing - Anti-HIF-1 alpha antibody [EPR16897-145] (AB308433)

Chromatin was prepared from HeLa cells treated with CoCl2 (350μM 20h+4h) add MG-132(10µM 4h). Cells were fixed with 1% formaldehyde for 10 minutes. ChIP was performed with 107 cells and 8 µg of ab308433 [EPR16897-145] or ab179483 [EPR16897]. ChIP DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 30 million reads. The Input control is also shown.

Immunoprecipitation - Anti-HIF-1 alpha antibody [EPR16897-145] (AB308433)
  • IP

Supplier Data

Immunoprecipitation - Anti-HIF-1 alpha antibody [EPR16897-145] (AB308433)

HIF-1 alpha was immunoprecipitated from 0.35 mg HCT116 (human colorectal carcinoma epithelial cell) treated with 0.5 mM DFO for 24 hour whole cell lysate with ab308433 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab308433 at 1/1000 dilution. VeriBlot for IP secondary antibody (HRP) (ab131366) was used at 1/5000 dilution.

Lane 1 : HCT116 (human colorectal carcinoma epithelial cell) treated with 0.5 mM DFO for 24 hour whole cell lysate
Lane 2 : ab308433 IP in HCT116 (human colorectal carcinoma epithelial cell) treated with 0.5 mM DFO for 24 hour whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab308433 in HCT116 treated with 0.5 mM DFO for 24 hour whole cell lysate

Blocking and dilution buffer and concentration : 5% NFDM/TBST.

Exposure time : 15 seconds

All lanes:

Immunoprecipitation - Anti-HIF-1 alpha antibody [EPR16897-145] (ab308433) at 1/1000 dilution

All lanes:

HCT116 (human colorectal carcinoma epithelial cell) treated with 0.5 mM DFO for 24 hour whole cell lysate at 10 µg

Secondary

All lanes:

Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution

Observed band size: 110 kDa

false

Exposure time: 15s

ChIP - Anti-HIF-1 alpha antibody [EPR16897-145] (AB308433)
  • ChIP

Supplier Data

ChIP - Anti-HIF-1 alpha antibody [EPR16897-145] (AB308433)

Chromatin was prepared from HeLa (human cervical adenocarcinoma epithelial cell) treated with DFO(0.5mM 24h) and HeLa non-treated according to the Abcam Dual-X-ChIP protocol*. Cells were fixed with 1.5 mM EGS for 30mins and then formaldehyde for 10min. The ChIP was performed with 25 µg of chromatin, 5 µg of ab308433 (red), or 5 µg of rabbit normal IgG ab172730 (gray) and 25 µl of Protein A/G Dynabeads. The immunoprecipitated DNA was quantified by real time PCR (Sybr green approach). Primers are from paper PMID : 28193910, 21447827 *Abcam Dual-X-ChIP protocol link

ChIP-sequencing - Anti-HIF-1 alpha antibody [EPR16897-145] (AB308433)
  • ChIP-seq

Supplier Data

ChIP-sequencing - Anti-HIF-1 alpha antibody [EPR16897-145] (AB308433)

Chromatin was prepared from HeLa cells treated with CoCl2 (350μM 20h+4h) add MG-132(10µM 4h). Cells were fixed with 1% formaldehyde for 10 minutes. ChIP was performed with 107 cells and 8 µg of ab308433 [EPR16897-145] or ab179483 [EPR16897]. ChIP DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 30 million reads. The Input control is also shown.

ChIP-sequencing - Anti-HIF-1 alpha antibody [EPR16897-145] (AB308433)
  • ChIP-seq

Supplier Data

ChIP-sequencing - Anti-HIF-1 alpha antibody [EPR16897-145] (AB308433)

Chromatin was prepared from HeLa cells treated with CoCl2 (350μM 20h+4h) add MG-132(10µM 4h). Cells were fixed with 1% formaldehyde for 10 minutes. ChIP was performed with 107 cells and 8 µg of ab308433 [EPR16897-145] or ab179483 [EPR16897]. ChIP DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 30 million reads. The Input control is also shown.

Immunoprecipitation - Anti-HIF-1 alpha antibody [EPR16897-145] (AB308433)
  • IP

Supplier Data

Immunoprecipitation - Anti-HIF-1 alpha antibody [EPR16897-145] (AB308433)

HIF-1 alpha was immunoprecipitated from 0.35 mg HeLa (human cervix adenocarcinoma epithelial cell) treated with 0.5 mM DFO for 24 hour whole cell lysate with ab308433 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab308433 at 1/1000 dilution. VeriBlot for IP secondary antibody (HRP) (ab131366) was used at 1/5000 dilution.

Lane 1 : HeLa (human cervix adenocarcinoma epithelial cell) treated with 0.5 mM DFO for 24 hour whole cell lysate
Lane 2 : ab308433 IP in HeLa (human cervix adenocarcinoma epithelial cell) treated with 0.5 mM DFO for 24 hour whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab308433 in HeLa treated with 0.5 mM DFO for 24 hour whole cell lysate

Blocking and dilution buffer and concentration : 5% NFDM/TBST.

Exposure time : 10 seconds

All lanes:

Immunoprecipitation - Anti-HIF-1 alpha antibody [EPR16897-145] (ab308433) at 1/1000 dilution

All lanes:

HeLa (human cervix adenocarcinoma epithelial cell) treated with 0.5 mM DFO for 24 hour whole cell lysate at 10 µg

Secondary

All lanes:

Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution

Observed band size: 110 kDa

false

Exposure time: 10s

Immunocytochemistry/ Immunofluorescence - Anti-HIF-1 alpha antibody [EPR16897-145] (AB308433)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-HIF-1 alpha antibody [EPR16897-145] (AB308433)

Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized bEnd.3 (mouse brain endothelial cell) cells labelling HIF-1 alpha with ab308433 at 1/100 (5.125 ug/ml) dilution, followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed antibody at 1/1000 2 ug/ml dilution (Green). Confocal images showing nuclear staining in bEnd.3 cells treated with DFO (2 mM) for 24 hours and showing no staining in untreated bEnd.3 cells.Image was taken with a confocal microscope(Leica-Microsystems, TCS SP8). ab195889 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at 1/200 2.5ug/ml dilution (Red). The Nuclear counterstain was DAPI (Blue). Secondary antibody only control : Secondary antibody is ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 2 ug/ml dilution.

Flow Cytometry (Intracellular) - Anti-HIF-1 alpha antibody [EPR16897-145] (AB308433)
  • Flow Cyt (Intra)

Supplier Data

Flow Cytometry (Intracellular) - Anti-HIF-1 alpha antibody [EPR16897-145] (AB308433)

Flow cytometric analysis of 4% paraformaldehyde fixed 90% methanol permeabilized bEND.3 (mouse brain endothelial cell) treated with 2mM DFO for 24h (Red) / untreated bEND.3 (Green) cells labelling HIF-1 alpha with ab308433 at 1/50 dilution (1 ug)/Red and Green (Red) compared with a Rabbit monoclonal IgG (ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). A Goat Anti-Rabbit IgG (Alexa Fluor® 488, ab150081) at 1/5000 dilution was used as the secondary antibody.

Western blot - Anti-HIF-1 alpha antibody [EPR16897-145] (AB308433)
  • WB

Supplier Data

Western blot - Anti-HIF-1 alpha antibody [EPR16897-145] (AB308433)

Blocking and diluting buffer and concentration : 5% NFDM/TBST.#Lysates/proteins at 20 µg per lane. Performed under reducing conditions. In Western blot, ab308433 was shown to bind specifically to HIF-1 alpha. A band was observed at 110 kDa in wild-type HCT116 cell lysates with whereas no signal observed at this size in HIF-1 alpha knockout cell line ab255394 (knockout cell lysate). The expression of HIF-1 alpha is upregulated in response to DFO treatment (PMID : 25075254). In Western blot, anti-GAPDH antibody (ab181602) loading control staining at 1/200000 dilution. Lysates were freshly made and used for Western blotting immediately to minimize protein degradation. Exposure time : 180 seconds.

All lanes:

Western blot - Anti-HIF-1 alpha antibody [EPR16897-145] (ab308433) at 1/1000 dilution

Lane 1:

Untreated HCT116 (human colorectal carcinoma epithelial cell) whole cell lysate at 20 µg

Lane 2:

HCT116 treated with 0.5 mM DFO for 24 hour whole cell lysate at 20 µg

Lane 3:

Untreated HIF-1 alpha knockout HCT116 whole cell lysate at 20 µg

Lane 4:

HIF-1 alpha knockout HCT116 treated with 0.5 mM DFO for 24 hour whole cell lysate at 20 µg

Lane 5:

Untreated bEnd.3 (mouse brain endothelioma) whole cell lysate at 20 µg

Lane 6:

bEnd.3 treated with 0.5 mM DFO for 24 hour whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 92 kDa

Observed band size: 110 kDa

false

Exposure time: 180s

Western blot - Anti-HIF-1 alpha antibody [EPR16897-145] (AB308433)
  • WB

Supplier Data

Western blot - Anti-HIF-1 alpha antibody [EPR16897-145] (AB308433)

Blocking and diluting buffer and concentration : 5% NFDM/TBST.

The expression of HIF-1 alpha is upregulated in response to DFO treatment (PMID : 25075254).

In Western blot, anti-GAPDH antibody (ab181602) loading control staining at 1/200000 dilution.

This blot was developed using a high sensitivity ECL substrate. The high-sensitivity ECL substrate used allows for the detection of proteins in the mid-femtogram range.

Lysates were freshly made and used for Western blotting immediately to minimize protein degradation.

All lanes:

Western blot - Anti-HIF-1 alpha antibody [EPR16897-145] (ab308433) at 1/1000 dilution

Lane 1:

Untreated HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg

Lane 2:

HeLa treated with 0.5 mM DFO for 24 hour whole cell lysate, at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 92 kDa

Observed band size: 110 kDa

true

Exposure time: 180s

ChIC/CUT&RUN sequencing - Anti-HIF-1 alpha antibody [EPR16897-145] (AB308433)
  • ChIC/CUT&RUN-seq

Lab

ChIC/CUT&RUN sequencing - Anti-HIF-1 alpha antibody [EPR16897-145] (AB308433)

ChIC/CUT&RUN was performed using a pAG-MNase at a final concentration of 700 ng/mL, 2.5 x 10^5 HeLa (Human epithelial cell line from cervix adenocarcinoma) cells treated with CoCl2 (350µM 20h+4h) add MG-132(10µM 4h) and 5 µg of ab308433 [EPR16897-145]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown.

The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.

ChIC/CUT&RUN sequencing - Anti-HIF-1 alpha antibody [EPR16897-145] (AB308433)
  • ChIC/CUT&RUN-seq

Lab

ChIC/CUT&RUN sequencing - Anti-HIF-1 alpha antibody [EPR16897-145] (AB308433)

ChIC/CUT&RUN was performed using a pAG-MNase at a final concentration of 700 ng/mL, 2.5 x 10^5 HeLa (Human epithelial cell line from cervix adenocarcinoma) cells treated with CoCl2 (350µM 20h+4h) add MG-132(10µM 4h) and 5 µg of ab308433 [EPR16897-145]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown.

The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.

ChIC/CUT&RUN sequencing - Anti-HIF-1 alpha antibody [EPR16897-145] (AB308433)
  • ChIC/CUT&RUN-seq

Lab

ChIC/CUT&RUN sequencing - Anti-HIF-1 alpha antibody [EPR16897-145] (AB308433)

ChIC/CUT&RUN was performed using a pAG-MNase at a final concentration of 700 ng/mL, 2.5 x 10^5 HeLa (Human epithelial cell line from cervix adenocarcinoma) cells treated with CoCl2 (350µM 20h+4h) add MG-132(10µM 4h) and 5 µg of ab308433 [EPR16897-145]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown.

The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.

  • Carrier free

    Anti-HIF-1 alpha antibody [EPR16897-145] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR16897-145

Isotype

IgG

Carrier free

No

Reacts with

Human, Mouse

Applications

IP, ChIC/CUT&RUN-seq, ChIP-seq, WB, ChIP, ICC/IF, Flow Cyt (Intra)

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

Unsuitable for mouse IP.

HIF-1 alpha expression is absent in most normal tissues (PMID: 12128120, 24835245, 11689469, 20217131).

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ChIPseq" : {"fullname" : "ChIP-sequencing", "shortname":"ChIP-seq"}, "ChIP" : {"fullname" : "ChIP", "shortname":"ChIP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ChICCUTRUNseq" : {"fullname" : "ChIC/CUT&RUN sequencing", "shortname":"ChIC/CUT&RUN-seq"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "ChIPseq-species-checked": "testedAndGuaranteed", "ChIPseq-species-dilution-info": "8 µg for 10^7 Cells", "ChIPseq-species-notes": "<p></p>", "ChIP-species-checked": "testedAndGuaranteed", "ChIP-species-dilution-info": "5 µg for 25 µg chromatin", "ChIP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/50", "FlowCytIntra-species-notes": "<p></p>", "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/30", "IP-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ChICCUTRUNseq-species-checked": "testedAndGuaranteed", "ChICCUTRUNseq-species-dilution-info": "5 µg", "ChICCUTRUNseq-species-notes": "<p></p>" }, "Mouse": { "ChIPseq-species-checked": "guaranteed", "ChIPseq-species-dilution-info": "", "ChIPseq-species-notes": "", "ChIP-species-checked": "guaranteed", "ChIP-species-dilution-info": "", "ChIP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/50", "FlowCytIntra-species-notes": "<p></p>", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ChICCUTRUNseq-species-checked": "guaranteed", "ChICCUTRUNseq-species-dilution-info": "", "ChICCUTRUNseq-species-notes": "" }, "Rat": { "ChIPseq-species-checked": "notRecommended", "ChIPseq-species-dilution-info": "", "ChIPseq-species-notes": "", "ChIP-species-checked": "notRecommended", "ChIP-species-dilution-info": "", "ChIP-species-notes": "", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCytIntra-species-checked": "notRecommended", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ChICCUTRUNseq-species-checked": "notRecommended", "ChICCUTRUNseq-species-dilution-info": "", "ChICCUTRUNseq-species-notes": "" } } }

Product details

What is this antibody validated in?
Anti-HIF-1 alpha antibody [EPR16897-145] (ab308433) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunoprecipitation (IP), Immunocytochemistry/immunofluorescence (ICC/IF), ChIP in Human, Mouse samples.

What is the molecular weight of HIF-1 alpha?
Anti-HIF-1 alpha [EPR16897-145] (ab308433) specifically detects a band for HIF-1 alpha (UniProt: Q16665) at a molecular weight of 92kDa.

Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.

Specificity confirmed
The specificity of Anti-HIF-1 alpha antibody [EPR16897-145] (ab308433) has been confirmed by Immunocytochemistry/ Immunofluorescence testing in HIF1A Knockout HCT 116 cell line, ab255394.

Other related products
We have a range of other formats of antibody clone [EPR16897-145] also available for your convenience: ab308433, Carrier free - ab308434

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

HIF-1 alpha also known as hypoxia-inducible factor 1-alpha is a transcription factor critical in cellular response to low oxygen levels. Its molecular weight usually ranges from 93 to 120 kDa. You can find HIF-1 alpha expressed in tissues throughout the body but its expression significantly increases under hypoxic conditions. Researchers often use the HIF-1a ELISA to measure its expression levels. HIF-1 alpha forms a complex with other proteins to perform its functions effectively.
Biological function summary

HIF-1 alpha regulates gene expression in response to hypoxic conditions in cells. It forms a complex with HIF-1 beta to activate transcription of various genes involved in energy metabolism angiogenesis and erythropoiesis. HIF-1 alpha enables cells to adapt to reduced oxygen availability allowing for cellular survival and function under stress. It plays an important role in promoting the expression of genes like VEGF and EPO which are important for vascular and red blood cell development respectively.

Pathways

HIF-1 alpha plays an integral role in the hypoxia signaling pathway and the glycolytic pathway. In the hypoxia signaling pathway HIF-1 alpha partners with VHL (Von Hippel-Lindau) protein that regulates its degradation under normal oxygen conditions. When oxygen levels drop HIF-1 alpha avoids degradation stabilizes and translocates into the nucleus to initiate transcription of hypoxia-responsive genes. The glycolytic pathway involvement highlights its function in adapting energy production under hypoxic conditions through collaboration with enzymes and transporters associated with glycolysis.

HIF-1 alpha has been implicated in cancer and ischemic diseases. Its role in promoting angiogenesis and metabolic adaptation makes it a contributor to tumor growth and survival collaborating with oncogenes such as c-Myc. In ischemic diseases like stroke or myocardial infarction HIF-1 alpha's ability to induce protective responses can mitigate tissue damage through regulation of survival pathways. Understanding these interactions helps in the development of therapeutic strategies targeting HIF-1 alpha in disease contexts.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

The protein expressed by the gene HIF1A functions as a master transcriptional regulator of the adaptive response to hypoxia, activating the transcription of over 40 genes under hypoxic conditions, including erythropoietin, glucose transporters, glycolytic enzymes, vascular endothelial growth factor, HILPDA, and others. These genes' protein products enhance oxygen delivery or facilitate metabolic adaptation to hypoxia. HIF1A is crucial for embryonic vascularization, tumor angiogenesis, and ischemic disease pathophysiology. Its activation requires transcriptional coactivators like CREBBP and EP300, with activity enhanced by interactions with NCOA1 and/or NCOA2. Interaction with redox regulatory protein APEX1 activates CTAD and enhances activation by NCOA1 and CREBBP. Additionally, HIF1A is involved in axonal distribution and mitochondrial transport in neurons during hypoxia. In the context of microbial infection, specifically human coronavirus SARS-CoV-2, HIF1A is necessary for glycolysis induction in monocytes, leading to a proinflammatory state, inducing expression of ACE2, cytokines, and promoting virus replication and monocyte inflammatory response. This supplementary information is collated from multiple sources and compiled automatically.
See full target information HIF1A

Publications (16)

Recent publications for all applications. Explore the full list and refine your search

Materials today. Bio 35:102306 PubMed41019494

2025

Selenium nanoparticles alleviate cobalt toxicity in artificial joint metal prostheses by inhibiting ferroptosis through activation of the PRDX6/GPX4 pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Pengcheng Xu,Fan Liu,Su Jiang,Baisheng Cai,Cong Ye,Yiming Sun,Yaping Wang,Jining Shen,Huan Zhou,Yake Liu

Journal of cellular and molecular medicine 29:e70703 PubMed40629256

2025

Hypoxia-Driven Regulation of Osteogenic Differentiation in Human Periosteal Stem Cells via the HIF-1α/miR-129-5p/BMP2 Axis.

Applications

Unspecified application

Species

Unspecified reactive species

Jiajia Lu,Xinyu Wang,Nan Lu,Aimin Chen,Lianbo Xiao

PloS one 20:e0325936 PubMed40601668

2025

PLZF promotes compensatory lung growth by increasing HPMEC proliferation and angiogenesis.

Applications

Unspecified application

Species

Unspecified reactive species

Jing Peng,Liang Ma,Zhonghui Wang,Yaxi Du,Qunfen Tao,Qiongchuan Wang,Li Zhao

Nature communications 16:5263 PubMed40480985

2025

A self-directed Trojanbot-enzymatic nanobot in neutrobot for active target therapy of glioblastoma.

Applications

Unspecified application

Species

Unspecified reactive species

Yuanyuan Gao,Meng Mao,Yue Li,Mingjun Xuan,Yingjie Wu,Qiang He

Journal of cellular and molecular medicine 29:e70598 PubMed40387552

2025

Ephedrine Attenuates LPS-Induced Acute Lung Injury in Mice by Inhibiting OTUB1 and Promoting K48 Ubiquitination of HIF1α.

Applications

Unspecified application

Species

Unspecified reactive species

Bo Zhou,Keke Zhao,Jiahui Xue,Fangling Zhou,Jin-Ao Duan,Yang Niu,Hanqing Wang

Cell death & disease 16:149 PubMed40032849

2025

Transcription factor ONECUT3 regulates HDAC6/HIF-1α activity to promote the Warburg effect and tumor growth in colorectal cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Ruixue Huo,Weihan Li,Hao Wu,Kexin He,Hao Wang,Shan Zhang,Shu-Heng Jiang,Rongkun Li,Junli Xue

Journal of cellular and molecular medicine 29:e70382 PubMed39993966

2025

MicroRNA Expression Profile in the Patient's Plasma Exosomes of Alcohol-Induced Osteonecrosis of Femoral Head: Potential Vascular Regulation Mechanism.

Applications

Unspecified application

Species

Unspecified reactive species

Wei Chen,Cheng Li,Zhe Yi,Gaojie Luo,Peiyao Zhang,Panfeng Wu,Fang Yu,Liming Qing,Juyu Tang

Advanced science (Weinheim, Baden-Wurttemberg, Germany) 12:e2412282 PubMed39887620

2025

Unraveling the Microenvironment and the Pathogenic Axis of HIF-1α-Visfatin-Fibrosis in Autoimmune Pancreatitis Using a Single-Cell Atlas.

Applications

Unspecified application

Species

Unspecified reactive species

Deyu Zhang,Congjia Ma,Zhen Wang,Yanfang Liu,Zaoqu Liu,Wanshun Li,Yue Liu,Chang Wu,Liqi Sun,Fei Jiang,Hui Jiang,Xiaoju Su,Lisi Peng,Jiayu Li,Xinyue Wang,Hua Yin,Dongling Wan,Yuyan Zhou,Xiaorong Tian,Shiyu Li,Zhendong Jin,Baoan Ji,Zhaoshen Li,Haojie Huang

BMC cancer 25:35 PubMed39780116

2025

Correlation analysis of DLG5 and PD-L1 expression in triple-negative breast cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Jingmin Che,Bo Chen,Xusheng Wang,Baoe Liu,Cuixiang Xu,Huxia Wang,Jingying Sun,Qing Feng,Xiangrong Zhao,Zhangjun Song

Cellular and molecular biology (Noisy-le-Grand, France) 70:85-91 PubMed38836676

2024

The combination of tetramethylpyrazine and vitamin A acid in the treatment of skin photoaging by activating the HIF-1α pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Weijun Chen,Jianyong Fan,Xuelian Zou,Yuansheng Wu
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com